<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36560620</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Rhinovirus Infection and Virus-Induced Asthma.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2616</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14122616</ELocationID><Abstract><AbstractText>While the aetiology of asthma is unclear, the onset and/or exacerbation of asthma may be associated with respiratory infections. Virus-induced asthma is also known as virus-associated/triggered asthma, and the reported main causative agent is rhinovirus (RV). Understanding the relationship between viral infections and asthma may overcome the gaps in deferential immunity between viral infections and allergies. Moreover, understanding the complicated cytokine networks involved in RV infection may be necessary. Therefore, the complexity of RV-induced asthma is not only owing to the response of airway and immune cells against viral infection, but also to allergic immune responses caused by the wide variety of cytokines produced by these cells. To better understand RV-induced asthma, it is necessary to elucidate the nature RV infections and the corresponding host defence mechanisms. In this review, we attempt to organise the complexity of RV-induced asthma to make it easily understandable for readers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Yuriko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki-shi 370-0006, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sada</LastName><ForeName>Mitsuru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki-shi 370-0006, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirai</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Advanced Medical Science Research Center, Gunma Paz University Research Institute, Shibukawa-shi 377-0008, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okayama</LastName><ForeName>Kaori</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki-shi 370-0006, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Ryusuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Advanced Medical Science Research Center, Gunma Paz University Research Institute, Shibukawa-shi 377-0008, Gunma, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bacteriology, Gunma University Graduate School of Medicine, Maebashi-shi 371-8514, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Mayumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Engineering, Faculty of Medical Technology, Gunma Paz University, Takasaki-shi 370-0006, Gunma, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okodo</LastName><ForeName>Mitsuaki</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6152-3217</Identifier><AffiliationInfo><Affiliation>Department of Medical Technology, Faculty of Health Sciences, Kyorin University, 5-4-1 Shimorenjaku, Mitaka-shi 181-8621, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsugawa</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7226-3000</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, Sapporo Medical University, Sapporo-shi 060-8543, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryo</LastName><ForeName>Akihide</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, School of Medicine, Yokohama City University, Yokohama-shi 236-0004, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Hirokazu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki-shi 370-0006, Gunma, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Medical Science Research Center, Gunma Paz University Research Institute, Shibukawa-shi 377-0008, Gunma, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006967" MajorTopicYN="Y">Hypersensitivity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">airway tissue remodelling</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword><Keyword MajorTopicYN="N">virus-induced asthma</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>2</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36560620</ArticleId><ArticleId IdType="pmc">PMC9781665</ArticleId><ArticleId IdType="doi">10.3390/v14122616</ArticleId><ArticleId IdType="pii">v14122616</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kusel M.M.H., de Klerk N.H., Kebadze T., Vohma V., Holt P.G., Johnston S.L., Sly P.D. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J. Allergy Clin. Immunol. 2007;119:1105–1110. doi: 10.1016/j.jaci.2006.12.669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2006.12.669</ArticleId><ArticleId IdType="pmc">PMC7125611</ArticleId><ArticleId IdType="pubmed">17353039</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston N.W., Sears M.R. Asthma exacerbations 1: Epidemiology. Thorax. 2006;61:722–728. doi: 10.1136/thx.2005.045161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2005.045161</ArticleId><ArticleId IdType="pmc">PMC2104697</ArticleId><ArticleId IdType="pubmed">16877691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurai D., Saraya T., Ishii H., Takizawa H. Virus-induced exacerbations in asthma and COPD. Front. Microbiol. 2013;4:293. doi: 10.3389/fmicb.2013.00293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2013.00293</ArticleId><ArticleId IdType="pmc">PMC3787546</ArticleId><ArticleId IdType="pubmed">24098299</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N., Lu X., Teague W.G., Kazerouni N., Anderson L.J., Erdman D.D. Novel human rhinoviruses and exacerbation of asthma in children. Emerg. Infect. Dis. 2008;14:1793. doi: 10.3201/eid1411.080386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1411.080386</ArticleId><ArticleId IdType="pmc">PMC2630738</ArticleId><ArticleId IdType="pubmed">18976575</ArticleId></ArticleIdList></Reference><Reference><Citation>Humberto E.T.B., Samuel A. Histology for Pathologists. Lippincott Williams &amp; Wilkins; Philadelphia, PA, USA: 2019.</Citation></Reference><Reference><Citation>Toews G.B. Cytokines and the lung. Eur. Respir. J. 2001;34:3s–17s. doi: 10.1183/09031936.01.00266001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.01.00266001</ArticleId><ArticleId IdType="pubmed">12392030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern J.E. Mechanisms of virus-induced asthma. J. Pediatr. 2003;142:S9–S13. doi: 10.1067/mpd.2003.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpd.2003.20</ArticleId><ArticleId IdType="pubmed">12584514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma: From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000;161:1720–1745. doi: 10.1164/ajrccm.161.5.9903102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.5.9903102</ArticleId><ArticleId IdType="pubmed">10806180</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Muhsen S., Johnson J.R., Hamid Q. Remodeling in asthma. J. Allergy Clin. Immunol. 2011;128:451–462. doi: 10.1016/j.jaci.2011.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.04.047</ArticleId><ArticleId IdType="pubmed">21636119</ArticleId></ArticleIdList></Reference><Reference><Citation>Czarnowicki T., Esaki H., Gonzalez J., Malajian D., Shemer A., Noda S., Talasila S., Berry A., Gray J., Becker L. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets. J. Allergy Clin. Immunol. 2015;136:941–951. doi: 10.1016/j.jaci.2015.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.05.049</ArticleId><ArticleId IdType="pmc">PMC4946641</ArticleId><ArticleId IdType="pubmed">26242300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura H., Yoshizumi M., Ishii H., Oishi K., Ryo A. Cytokine production and signaling pathways in respiratory virus infection. Front. Microbiol. 2013;4:276. doi: 10.3389/fmicb.2013.00276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2013.00276</ArticleId><ArticleId IdType="pmc">PMC3774987</ArticleId><ArticleId IdType="pubmed">24062733</ArticleId></ArticleIdList></Reference><Reference><Citation>James E., Gern A.C. Fields Virology, 6th Edition. Clin. Infect. Dis. 2013;59:531–549. doi: 10.1093/cid/ciu346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu346</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs S.E., Lamson D.M., St George K., Walsh T.J. Human rhinoviruses. Clin. Microbiol. Rev. 2013;26:135–162. doi: 10.1128/CMR.00077-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00077-12</ArticleId><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre C.L., Knowles N.J., Simmonds P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J. Gen. Virol. 2013;94:1791. doi: 10.1099/vir.0.053686-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.053686-0</ArticleId><ArticleId IdType="pmc">PMC3749525</ArticleId><ArticleId IdType="pubmed">23677786</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshrari A.S., Hudu S.A., Asdaq S.M., Ali A.M., Kin C.V., Omar A.R., Pei C.P., Sekawi Z. Bioinformatics analysis of rhinovirus capsid proteins VP1–4 sequences for cross-serotype vaccine development. J. Infect. Public Health. 2021;14:1603–1611. doi: 10.1016/j.jiph.2021.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.09.001</ArticleId><ArticleId IdType="pubmed">34624714</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliam Leitch E.C., Cabrerizo M., Cardosa J., Harvala H., Ivanova O.E., Kroes A.C., Lukashev A., Muir P., Odoom J., Roivainen M., et al. Evolutionary dynamics and temporal/geographical correlates of recombination in the human enterovirus echovirus types 9, 11, and 30. J. Virol. 2010;84:9292–9300. doi: 10.1128/JVI.00783-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00783-10</ArticleId><ArticleId IdType="pmc">PMC2937653</ArticleId><ArticleId IdType="pubmed">20610722</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet S., Palmenberg A.C., Gern J.E. Rhinoviruses and their receptors. Chest. 2019;155:1018–1025. doi: 10.1016/j.chest.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.12.012</ArticleId><ArticleId IdType="pmc">PMC6533451</ArticleId><ArticleId IdType="pubmed">30659817</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X.-H., Pang L.-L., Yang J., Jin Y. Comparison of immune response to human rhinovirus C and respiratory syncytial virus in highly differentiated human airway epithelial cells. Virol. J. 2022;19:81. doi: 10.1186/s12985-022-01805-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01805-2</ArticleId><ArticleId IdType="pmc">PMC9107719</ArticleId><ArticleId IdType="pubmed">35570279</ArticleId></ArticleIdList></Reference><Reference><Citation>Romagnani S. Human TH1 and TH2 subsets: Doubt no more. Immunol. Today. 1991;12:256–257. doi: 10.1016/0167-5699(91)90120-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5699(91)90120-I</ArticleId><ArticleId IdType="pubmed">1680337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuniga E.I., Macal M., Lewis G.M., Harker J.A. Innate and Adaptive Immune Regulation During Chronic Viral Infections. Annu. Rev. Virol. 2015;2:573–597. doi: 10.1146/annurev-virology-100114-055226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-100114-055226</ArticleId><ArticleId IdType="pmc">PMC4785831</ArticleId><ArticleId IdType="pubmed">26958929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhang Y., Gu W., Sun B. TH1/TH2 cell differentiation and molecular signals. Adv. Exp. Med. Biol. 2014;841:15–44.</Citation><ArticleIdList><ArticleId IdType="pubmed">25261203</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003;3:133–146. doi: 10.1038/nri1001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1001</ArticleId><ArticleId IdType="pubmed">12563297</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo P.E., Quenet F., Alric P., Mourregot A., Neron M., Portales F., Rouanet P., Carrier G. Distal Pancreatectomy with Celiac Axis Resection (Modified Appleby Procedure) and Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Chemoradiation Therapy. Ann. Surg. Oncol. 2021;28:1106–1108. doi: 10.1245/s10434-020-08740-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-020-08740-y</ArticleId><ArticleId IdType="pubmed">32588265</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic dermatitis. J. Clin. Investig. 2004;113:651–657. doi: 10.1172/JCI21060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI21060</ArticleId><ArticleId IdType="pmc">PMC351324</ArticleId><ArticleId IdType="pubmed">14991059</ArticleId></ArticleIdList></Reference><Reference><Citation>Corry D.B., Kheradmand F. Induction and regulation of the IgE response. Nature. 1999;402:B18–B23. doi: 10.1038/35037014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35037014</ArticleId><ArticleId IdType="pubmed">10586891</ArticleId></ArticleIdList></Reference><Reference><Citation>Deo S.S., Mistry K.J., Kakade A.M., Niphadkar P.V. Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India. 2010;27:66–71. doi: 10.4103/0970-2113.63609.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-2113.63609</ArticleId><ArticleId IdType="pmc">PMC2893428</ArticleId><ArticleId IdType="pubmed">20616938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson L.A. Atopic allergies and contact allergies. In: Wigzell L.A., editor. Immunology. Butterworth-Heinemann; Oxford, UK: 1985. pp. 198–209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-407-00372-9.50021-3</ArticleId></ArticleIdList></Reference><Reference><Citation>And K.I., Ishizaka T. Mechanisms of reaginic hypersensitivity and IgE antibody response. Immunol. Rev. 1978;41:109–148. doi: 10.1111/j.1600-065X.1978.tb01462.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.1978.tb01462.x</ArticleId><ArticleId IdType="pubmed">81546</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirahara K., Nakayama T. CD4+ T-cell subsets in inflammatory diseases: Beyond the Th 1/Th 2 paradigm. Int. Immunol. 2016;28:163–171. doi: 10.1093/intimm/dxw006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxw006</ArticleId><ArticleId IdType="pmc">PMC4889886</ArticleId><ArticleId IdType="pubmed">26874355</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand S. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: New immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut. 2009;58:1152–1167. doi: 10.1136/gut.2008.163667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2008.163667</ArticleId><ArticleId IdType="pubmed">19592695</ArticleId></ArticleIdList></Reference><Reference><Citation>Caminati M., Pham D.L., Bagnasco D., Canonica G.W. Type 2 immunity in asthma. World Allergy Organ. J. 2018;11:13. doi: 10.1186/s40413-018-0192-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40413-018-0192-5</ArticleId><ArticleId IdType="pmc">PMC6020328</ArticleId><ArticleId IdType="pubmed">29988331</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M., Rajput C., Hong J.Y., Lei J., Hinde J.L., Wu Q., Bentley J.K., Hershenson M.B. The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice. J. Immunol. 2017;199:1308–1318. doi: 10.4049/jimmunol.1700216.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700216</ArticleId><ArticleId IdType="pmc">PMC5548608</ArticleId><ArticleId IdType="pubmed">28701507</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddur M.S., Miossec P., Kaveri S.V., Bayry J. Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies. Am. J. Pathol. 2012;181:8–18. doi: 10.1016/j.ajpath.2012.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2012.03.044</ArticleId><ArticleId IdType="pubmed">22640807</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinley L., Alcorn J.F., Peterson A., DuPont R.B., Kapadia S., Logar A., Henry A., Irvin C.G., Piganelli J.D., Ray A. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 2008;181:4089–4097. doi: 10.4049/jimmunol.181.6.4089.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.6.4089</ArticleId><ArticleId IdType="pmc">PMC3638757</ArticleId><ArticleId IdType="pubmed">18768865</ArticleId></ArticleIdList></Reference><Reference><Citation>Makris S., Johnston S. Recent advances in understanding rhinovirus immunity. F1000 Res. 2018;7:1537. doi: 10.12688/f1000research.15337.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.15337.1</ArticleId><ArticleId IdType="pmc">PMC6173106</ArticleId><ArticleId IdType="pubmed">30345002</ArticleId></ArticleIdList></Reference><Reference><Citation>Simbirtsev A.S., Kozlov I.G. Cytokine System. In: Kamkin A., Kiseleva I., editors. Mechanical Stretch and Cytokines. Springer; Dordrecht, The Netherlands: 2012. pp. 1–33.</Citation></Reference><Reference><Citation>Induction and Regulation of IFNs During Viral Infections. J. Interferon Cytokine Res. 2004;24:439–454. doi: 10.1089/1079990041689665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/1079990041689665</ArticleId><ArticleId IdType="pubmed">15320958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., Paludan S.R. Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo. J. Virol. 2006;80:4501–4509. doi: 10.1128/JVI.80.9.4501-4509.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.9.4501-4509.2006</ArticleId><ArticleId IdType="pmc">PMC1472004</ArticleId><ArticleId IdType="pubmed">16611910</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry A.K., Chen G., Zheng D., Tang H., Cheng G. The host type I interferon response to viral and bacterial infections. Cell Res. 2005;15:407–422. doi: 10.1038/sj.cr.7290309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7290309</ArticleId><ArticleId IdType="pubmed">15987599</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F., Mayer-Barber K., Sher A., Wack A., O’garra A. Type I interferons in infectious disease. Nat. Rev. Immunol. 2015;15:87–103. doi: 10.1038/nri3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Sada M., Watanabe M., Inui T., Nakamoto K., Hirata A., Nakamura M., Honda K., Saraya T., Kurai D., Kimura H. Ruxolitinib inhibits poly (I:C) and type 2 cytokines-induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma. Immun. Inflamm. Dis. 2021;9:363–373. doi: 10.1002/iid3.397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.397</ArticleId><ArticleId IdType="pmc">PMC8127547</ArticleId><ArticleId IdType="pubmed">33534941</ArticleId></ArticleIdList></Reference><Reference><Citation>Galkina E., Thatte J., Dabak V., Williams M.B., Ley K., Braciale T.J. Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J. Clin. Investig. 2005;115:3473–3483. doi: 10.1172/JCI24482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI24482</ArticleId><ArticleId IdType="pmc">PMC1288831</ArticleId><ArticleId IdType="pubmed">16308575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohlmeier J.E., Miller S.C., Smith J., Lu B., Gerard C., Cookenham T., Roberts A.D., Woodland D.L. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity. 2008;29:101–113. doi: 10.1016/j.immuni.2008.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.05.011</ArticleId><ArticleId IdType="pmc">PMC2519120</ArticleId><ArticleId IdType="pubmed">18617426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekkanat K.K., Maassab H., Miller A., Berlin A.A., Kunkel S.L., Lukacs N.W. RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease. Eur. J. Immunol. 2002;32:3276–3284. doi: 10.1002/1521-4141(200211)32:11&lt;3276::AID-IMMU3276&gt;3.0.CO;2-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1521-4141(200211)32:11&lt;3276::AID-IMMU3276&gt;3.0.CO;2-5</ArticleId><ArticleId IdType="pubmed">12555673</ArticleId></ArticleIdList></Reference><Reference><Citation>Culley F.J., Pennycook A.M., Tregoning J.S., Dodd J.S., Walzl G., Wells T.N., Hussell T., Openshaw P.J. Role of CCL5 (RANTES) in viral lung disease. J. Virol. 2006;80:8151–8157. doi: 10.1128/JVI.00496-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00496-06</ArticleId><ArticleId IdType="pmc">PMC1563837</ArticleId><ArticleId IdType="pubmed">16873271</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer S., Gutu C.S., Grund J.C., Chiriac M.T., Zirlik S., Finotto S. Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma. Front. Immunol. 2021;12:731807. doi: 10.3389/fimmu.2021.731807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.731807</ArticleId><ArticleId IdType="pmc">PMC8660125</ArticleId><ArticleId IdType="pubmed">34899691</ArticleId></ArticleIdList></Reference><Reference><Citation>Galani I.E., Triantafyllia V., Eleminiadou E.E., Koltsida O., Stavropoulos A., Manioudaki M., Thanos D., Doyle S.E., Kotenko S.V., Thanopoulou K., et al. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness. Immunity. 2017;46:875–890. doi: 10.1016/j.immuni.2017.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.04.025</ArticleId><ArticleId IdType="pubmed">28514692</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch S., Finotto S. Role of Interferon-λ in Allergic Asthma. J. Innate Immun. 2015;7:224–230. doi: 10.1159/000369459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369459</ArticleId><ArticleId IdType="pmc">PMC6738890</ArticleId><ArticleId IdType="pubmed">25592858</ArticleId></ArticleIdList></Reference><Reference><Citation>Won J., Gil C.H., Jo A., Kim H.J. Inhaled delivery of Interferon-lambda restricts epithelial-derived Th2 inflammation in allergic asthma. Cytokine. 2019;119:32–36. doi: 10.1016/j.cyto.2019.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2019.02.010</ArticleId><ArticleId IdType="pubmed">30861490</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcomb D.C., Sajjan U.S., Nagarkar D.R., Goldsmith A.M., Bentley J.K., Hershenson M.B. Cooperative effects of rhinovirus and TNF-α on airway epithelial cell chemokine expression. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2007;293:L1021–L1028. doi: 10.1152/ajplung.00060.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00060.2007</ArticleId><ArticleId IdType="pubmed">17631613</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Lin J.-X., Leonard W.J. IL-2 family cytokines: New insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 2011;23:598–604. doi: 10.1016/j.coi.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.08.003</ArticleId><ArticleId IdType="pmc">PMC3405730</ArticleId><ArticleId IdType="pubmed">21889323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton J.A. GM-CSF in inflammation. J. Exp. Med. 2020;217:e20190945. doi: 10.1084/jem.20190945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190945</ArticleId><ArticleId IdType="pmc">PMC7037240</ArticleId><ArticleId IdType="pubmed">31611249</ArticleId></ArticleIdList></Reference><Reference><Citation>Smiley S.T., Grusby M.J. Interleukin 4. In: Delves P.J., editor. Encyclopedia of Immunology. 2nd ed. Elsevier; Oxford, UK: 1998. pp. 1451–1453.</Citation></Reference><Reference><Citation>Fulkerson P.C., Rothenberg M.E. Chapter One—Eosinophil Development, Disease Involvement, and Therapeutic Suppression. In: Alt F., editor. Advances in Immunology. Volume 138. Academic Press; Cambridge, MA, USA: 2018. pp. 1–34.</Citation><ArticleIdList><ArticleId IdType="pubmed">29731004</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D.E. Cytokines and Chemokines. In: Mahy B.W.J., Van Regenmortel M.H.V., editors. Encyclopedia of VirologyI. 3rd ed. Academic Press; Oxford, UK: 2008. pp. 620–624.</Citation></Reference><Reference><Citation>Matsuda T., Kishimoto T. Interleukin 6. In: Delves P.J., editor. Encyclopedia of Immunology. 2nd ed. Elsevier; Oxford, UK: 1998. pp. 1458–1461.</Citation></Reference><Reference><Citation>Sahiner U., Akdis M., Akdis C.A. 1—Introduction to Mechanisms of Allergic Diseases. In: O’Hehir R.E., Holgate S.T., Hershey G.K.K., Sheikh A., editors. Allergy Essentials. 2nd ed. Elsevier; Philadelphia, PA, USA: 2022. pp. 1–24.</Citation></Reference><Reference><Citation>Mak T.W., Saunders M.E. 17—Cytokines and Cytokine Receptors. In: Mak T.W., Saunders M.E., editors. The Immune Response. Academic Press; Burlington, VT, USA: 2006. pp. 463–516.</Citation></Reference><Reference><Citation>Ohne Y., Silver J.S., Thompson-Snipes L., Collet M.A., Blanck J.P., Cantarel B.L., Copenhaver A.M., Humbles A.A., Liu Y.-J. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat. Immunol. 2016;17:646–655. doi: 10.1038/ni.3447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3447</ArticleId><ArticleId IdType="pubmed">27111142</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D.J., Makrinioti H., Rana B.M., Shamji B.W., Trujillo-Torralbo M.-B., Footitt J., Del-Rosario J., Telcian A.G., Nikonova A., Zhu J. IL-33–dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 2014;190:1373–1382. doi: 10.1164/rccm.201406-1039OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201406-1039OC</ArticleId><ArticleId IdType="pmc">PMC4299647</ArticleId><ArticleId IdType="pubmed">25350863</ArticleId></ArticleIdList></Reference><Reference><Citation>Burleson S.C.M., Fick R.B., Mannie M.D., Olmstead S.G., Van Scott M.R. Chapter 35—The Immune Basis of Allergic Lung Disease. In: Parent R.A., editor. Comparative Biology of the Normal Lung. 2nd ed. Academic Press; San Diego, CA, USA: 2015. pp. 683–719.</Citation></Reference><Reference><Citation>Fujiwara K., Matsukawa A., Ohkawara S., Takagi K., Yoshinaga M. Functional distinction between CXC chemokines, interleukin-8 (IL-8), and growth related oncogene (GRO)alpha in neutrophil infiltration. Lab. Investig. 2002;82:15–23. doi: 10.1038/labinvest.3780391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3780391</ArticleId><ArticleId IdType="pubmed">11796822</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Alwan L.A., Chang Y., Mogas A., Halayko A.J., Baglole C.J., Martin J.G., Rousseau S., Eidelman D.H., Hamid Q. Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration. J. Immunol. 2013;191:2731–2741. doi: 10.4049/jimmunol.1203421.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203421</ArticleId><ArticleId IdType="pmc">PMC3748335</ArticleId><ArticleId IdType="pubmed">23904157</ArticleId></ArticleIdList></Reference><Reference><Citation>Walz A., Schmutz P., Mueller C., Schnyder-Candrian S. Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J. Leukoc. Biol. 1997;62:604–611. doi: 10.1002/jlb.62.5.604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.62.5.604</ArticleId><ArticleId IdType="pubmed">9365115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2003;284:L566–L577. doi: 10.1152/ajplung.00233.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00233.2002</ArticleId><ArticleId IdType="pubmed">12618418</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M., Guo S., Hibbert J.M., Jain V., Singh N., Wilson N.O., Stiles J.K. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22:121–130. doi: 10.1016/j.cytogfr.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2011.06.001</ArticleId><ArticleId IdType="pmc">PMC3203691</ArticleId><ArticleId IdType="pubmed">21802343</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Anshita D., Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. Int. Immunopharmacol. 2021;101:107598. doi: 10.1016/j.intimp.2021.107598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107598</ArticleId><ArticleId IdType="pmc">PMC8135227</ArticleId><ArticleId IdType="pubmed">34233864</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer M., von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 2004;36:1882–1886. doi: 10.1016/j.biocel.2003.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2003.10.019</ArticleId><ArticleId IdType="pubmed">15203102</ArticleId></ArticleIdList></Reference><Reference><Citation>Rot A., Krieger M., Brunner T., Bischoff S.C., Schall T., Dahinden C. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 1992;176:1489–1495. doi: 10.1084/jem.176.6.1489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.176.6.1489</ArticleId><ArticleId IdType="pmc">PMC2119467</ArticleId><ArticleId IdType="pubmed">1281207</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy J.A. The unexpected pleiotropic activities of RANTES. J. Immunol. 2009;182:3945–3946. doi: 10.4049/jimmunol.0990015.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0990015</ArticleId><ArticleId IdType="pubmed">19299688</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., Celestin J., Leder P., Luster A.D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 1996;2:449–456. doi: 10.1038/nm0496-449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0496-449</ArticleId><ArticleId IdType="pubmed">8597956</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Borgne M., Etchart N., Goubier A., Lira S.A., Sirard J.C., van Rooijen N., Caux C., Aït-Yahia S., Vicari A., Kaiserlian D., et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity. 2006;24:191–201. doi: 10.1016/j.immuni.2006.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.01.005</ArticleId><ArticleId IdType="pubmed">16473831</ArticleId></ArticleIdList></Reference><Reference><Citation>Roan F., Bell B.D., Stoklasek T.A., Kitajima M., Han H., Ziegler S.F. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J. Leukoc. Biol. 2012;91:877–886. doi: 10.1189/jlb.1211622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1211622</ArticleId><ArticleId IdType="pmc">PMC3360473</ArticleId><ArticleId IdType="pubmed">22442496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi M.R., Merlino G. The Two Faces of Interferon-γ in Cancer. Clin. Cancer Res. 2011;17:6118–6124. doi: 10.1158/1078-0432.CCR-11-0482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-11-0482</ArticleId><ArticleId IdType="pmc">PMC3186825</ArticleId><ArticleId IdType="pubmed">21705455</ArticleId></ArticleIdList></Reference><Reference><Citation>Atzeni F., Sarzi-Puttini P. Tumor Necrosis Factor. In: Maloy S., Hughes K., editors. Brenner’s Encyclopedia of Genetics. 2nd ed. Academic Press; San Diego, CA, USA: 2013. pp. 229–231.</Citation></Reference><Reference><Citation>Aronson J.K., editor. Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 15th ed. Elsevier; Amsterdam, The Netherlands: 2006. Tumor necrosis factor alfa; pp. 3537–3538.</Citation></Reference><Reference><Citation>Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986;136:2348–2357.</Citation><ArticleIdList><ArticleId IdType="pubmed">2419430</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher M.J., Zhu J. Recent advances in understanding the Th1/Th2 effector choice. Fac. Rev. 2021;10:30. doi: 10.12703/r/10-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.12703/r/10-30</ArticleId><ArticleId IdType="pmc">PMC8009194</ArticleId><ArticleId IdType="pubmed">33817699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.M.-Y., Yip T.-F., Yan S., Jin D.-Y., Wei H.-L., Guo R.-T., Peiris J.S.M. Recognition of double-stranded RNA and regulation of interferon pathway by toll-like receptor 10. Front. Immunol. 2018;9:516. doi: 10.3389/fimmu.2018.00516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00516</ArticleId><ArticleId IdType="pmc">PMC5865411</ArticleId><ArticleId IdType="pubmed">29616030</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto M., Seya T. TLR3: Interferon induction by double-stranded RNA including poly(I:C) Adv. Drug Deliv. Rev. 2008;60:805–812. doi: 10.1016/j.addr.2007.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2007.11.005</ArticleId><ArticleId IdType="pubmed">18262679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Zhang J., Yu F.S. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology. 2006;117:11–21. doi: 10.1111/j.1365-2567.2005.02258.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2005.02258.x</ArticleId><ArticleId IdType="pmc">PMC1782193</ArticleId><ArticleId IdType="pubmed">16423036</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamoto K., Watanabe M., Sada M., Inui T., Nakamura M., Honda K., Wada H., Ishii H., Takizawa H. Pseudomonas aeruginosa-derived flagellin stimulates IL-6 and IL-8 production in human bronchial epithelial cells: A potential mechanism for progression and exacerbation of COPD. Exp. Lung Res. 2019;45:255–266. doi: 10.1080/01902148.2019.1665147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01902148.2019.1665147</ArticleId><ArticleId IdType="pubmed">31517562</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalik M., Wójcik-Pszczoła K., Paw M., Wnuk D., Koczurkiewicz P., Sanak M., Pękala E., Madeja Z. Fibroblast-to-myofibroblast transition in bronchial asthma. Cell. Mol. Life Sci. 2018;75:3943–3961. doi: 10.1007/s00018-018-2899-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2899-4</ArticleId><ArticleId IdType="pmc">PMC6182337</ArticleId><ArticleId IdType="pubmed">30101406</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes I., Mathur S.K., Espenshade B.M., Mori Y., Varga J., Ackerman S.J. Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: Implications in fibrogenesis. J. Allergy Clin. Immunol. 2005;116:796–804. doi: 10.1016/j.jaci.2005.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.06.031</ArticleId><ArticleId IdType="pubmed">16210053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Nagarkar D.R., Bowman E.R., Schneider D., Gosangi B., Lei J., Zhao Y., McHenry C.L., Burgens R.V., Miller D.J. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 2009;183:6989–6997. doi: 10.4049/jimmunol.0901386.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901386</ArticleId><ArticleId IdType="pmc">PMC2920602</ArticleId><ArticleId IdType="pubmed">19890046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato A., Favoreto S., Avila P.C., Schleimer R.P. TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J. Immunol. 2007;179:1080–1087. doi: 10.4049/jimmunol.179.2.1080.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.2.1080</ArticleId><ArticleId IdType="pmc">PMC2220044</ArticleId><ArticleId IdType="pubmed">17617600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewson C.A., Jardine A., Edwards M.R., Laza-Stanca V., Johnston S.L. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J. Virol. 2005;79:12273–12279. doi: 10.1128/JVI.79.19.12273-12279.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.19.12273-12279.2005</ArticleId><ArticleId IdType="pmc">PMC1211516</ArticleId><ArticleId IdType="pubmed">16160153</ArticleId></ArticleIdList></Reference><Reference><Citation>Xagorari A., Chlichlia K. Toll-like receptors and viruses: Induction of innate antiviral immune responses. Open Microbiol. J. 2008;2:49. doi: 10.2174/1874285800802010049.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874285800802010049</ArticleId><ArticleId IdType="pmc">PMC2593046</ArticleId><ArticleId IdType="pubmed">19088911</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron G., Duluc D., Frémaux I., Jeannin P., David C., Gascan H., Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7/8: Flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells. J. Immunol. 2005;175:1551–1557. doi: 10.4049/jimmunol.175.3.1551.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.3.1551</ArticleId><ArticleId IdType="pubmed">16034093</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukura S., Kokubu F., Kurokawa M., Kawaguchi M., Ieki K., Kuga H., Odaka M., Suzuki S., Watanabe S., Homma T. Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int. Arch. Allergy Immunol. 2007;143:80–83. doi: 10.1159/000101411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000101411</ArticleId><ArticleId IdType="pubmed">17541283</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale F., Giordano P., Chinellato I., Tesse R. Respiratory epithelial imbalances in asthma pathophysiology. Allergy Asthma Proc. 2013;34:143–149. doi: 10.2500/aap.2013.34.3631.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2013.34.3631</ArticleId><ArticleId IdType="pubmed">23484889</ArticleId></ArticleIdList></Reference><Reference><Citation>Comstock A.T., Ganesan S., Chattoraj A., Faris A.N., Margolis B.L., Hershenson M.B., Sajjan U.S. Rhinovirus-induced barrier dysfunction in polarized airway epithelial cells is mediated by NADPH oxidase 1. J. Virol. 2011;85:6795–6808. doi: 10.1128/JVI.02074-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02074-10</ArticleId><ArticleId IdType="pmc">PMC3126521</ArticleId><ArticleId IdType="pubmed">21507984</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan D., McCracken C.E., Kopleman H.B., Kyu S.Y., Lee F.E.-H., Lu X., Anderson L.J. Human rhinovirus induced cytokine/chemokine responses in human airway epithelial and immune cells. PLoS ONE. 2014;9:e114322. doi: 10.1371/journal.pone.0114322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114322</ArticleId><ArticleId IdType="pmc">PMC4264758</ArticleId><ArticleId IdType="pubmed">25500821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghildyal R., Dagher H., Donninger H., de Silva D., Li X., Freezer N.J., Wilson J.W., Bardin P.G. Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor. J. Med. Virol. 2005;75:608–615. doi: 10.1002/jmv.20315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20315</ArticleId><ArticleId IdType="pubmed">15714497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden F.G. Rhinovirus and the lower respiratory tract. Rev. Med. Virol. 2004;14:17–31. doi: 10.1002/rmv.406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.406</ArticleId><ArticleId IdType="pmc">PMC7169234</ArticleId><ArticleId IdType="pubmed">14716689</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehling L.M., Heymann P.W., Wright P.W., Eccles J.D., Agrawal R., Carper H.T., Murphy D.D., Workman L.J., Word C.R., Ratcliffe S.J., et al. Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma. J. Allergy Clin. Immunol. 2020;146:555–570. doi: 10.1016/j.jaci.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7483727</ArticleId><ArticleId IdType="pubmed">32320734</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern J.E., Vrtis R., Grindle K.A., Swenson C., Busse W.W. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am. J. Respir. Crit. Care Med. 2000;162:2226–2231. doi: 10.1164/ajrccm.162.6.2003019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.162.6.2003019</ArticleId><ArticleId IdType="pubmed">11112143</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas B.J., Lindsay M., Dagher H., Freezer N.J., Li D., Ghildyal R., Bardin P.G. Transforming growth factor-beta enhances rhinovirus infection by diminishing early innate responses. Am. J. Respir. Cell Mol. Biol. 2009;41:339–347. doi: 10.1165/rcmb.2008-0316OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2008-0316OC</ArticleId><ArticleId IdType="pubmed">19168696</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 1998;8:275–283. doi: 10.1016/S1074-7613(00)80533-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)80533-6</ArticleId><ArticleId IdType="pubmed">9529145</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.M., An J. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. 2007;45:27–37. doi: 10.1097/AIA.0b013e318034194e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AIA.0b013e318034194e</ArticleId><ArticleId IdType="pmc">PMC2785020</ArticleId><ArticleId IdType="pubmed">17426506</ArticleId></ArticleIdList></Reference><Reference><Citation>Gern J.E., Busse W.W. Association of rhinovirus infections with asthma. Clin. Microbiol. Rev. 1999;12:9–18. doi: 10.1128/CMR.12.1.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.12.1.9</ArticleId><ArticleId IdType="pmc">PMC88904</ArticleId><ArticleId IdType="pubmed">9880472</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomino D.C., Marti L.C. Chemokines and immunity. Einstein. 2015;13:469–473. doi: 10.1590/S1679-45082015RB3438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1679-45082015RB3438</ArticleId><ArticleId IdType="pmc">PMC4943798</ArticleId><ArticleId IdType="pubmed">26466066</ArticleId></ArticleIdList></Reference><Reference><Citation>Juremalm M., Nilsson G. Chemokine receptor expression by mast cells. Chem. Immunol. Allergy. 2005;87:130–144. doi: 10.1159/000087640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000087640</ArticleId><ArticleId IdType="pubmed">16107768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheeran P., Jafri H., Carubelli C., Saavedra J., Johnson C., Krisher K., Sánchez P.J., Ramilo O. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr. Infect. Dis. J. 1999;18:115–122. doi: 10.1097/00006454-199902000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199902000-00007</ArticleId><ArticleId IdType="pubmed">10048682</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkerts G., Busse W.W., Nijkamp F.P., Sorkness R., Gern J.E. Virus-induced airway hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med. 1998;157:1708–1720. doi: 10.1164/ajrccm.157.6.9707163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.157.6.9707163</ArticleId><ArticleId IdType="pubmed">9620896</ArticleId></ArticleIdList></Reference><Reference><Citation>van Erp E.A., Luytjes W., Ferwerda G., van Kasteren P.B. Fc-Mediated Antibody Effector Functions during Respiratory Syncytial Virus Infection and Disease. Front. Immunol. 2019;10:548. doi: 10.3389/fimmu.2019.00548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00548</ArticleId><ArticleId IdType="pmc">PMC6438959</ArticleId><ArticleId IdType="pubmed">30967872</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S. Follicular helper CD4 T cells (Tfh) Annu. Rev. Immunol. 2011;29:621–663. doi: 10.1146/annurev-immunol-031210-101400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-031210-101400</ArticleId><ArticleId IdType="pubmed">21314428</ArticleId></ArticleIdList></Reference><Reference><Citation>Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999;17:593–623. doi: 10.1146/annurev.immunol.17.1.593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.17.1.593</ArticleId><ArticleId IdType="pubmed">10358769</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston S.L. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc. Am. Thorac. Soc. 2007;4:267–270. doi: 10.1513/pats.200701-030AW.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.200701-030AW</ArticleId><ArticleId IdType="pubmed">17607011</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark P.A., Gibson P.G. Asthma exacerbations 3: Pathogenesis. Thorax. 2006;61:909–915. doi: 10.1136/thx.2005.045187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2005.045187</ArticleId><ArticleId IdType="pmc">PMC2104753</ArticleId><ArticleId IdType="pubmed">17008482</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikhail I., Grayson M.H. Asthma and viral infections: An intricate relationship. Ann. Allergy Asthma Immunol. 2019;123:352–358. doi: 10.1016/j.anai.2019.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2019.06.020</ArticleId><ArticleId IdType="pmc">PMC7111180</ArticleId><ArticleId IdType="pubmed">31276807</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes P.J. Th2 cytokines and asthma: An introduction. Respir. Res. 2001;2:64. doi: 10.1186/rr39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/rr39</ArticleId><ArticleId IdType="pmc">PMC59569</ArticleId><ArticleId IdType="pubmed">11686866</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt E.B., Sivaprasad U. Th2 Cytokines and Atopic Dermatitis. J. Clin. Cell. Immunol. 2011;2:1000110. doi: 10.4172/2155-9899.1000110.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9899.1000110</ArticleId><ArticleId IdType="pmc">PMC3189506</ArticleId><ArticleId IdType="pubmed">21994899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay A.B., Phipps S., Robinson D.S. A role for eosinophils in airway remodelling in asthma. Trends Immunol. 2004;25:477–482. doi: 10.1016/j.it.2004.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.07.006</ArticleId><ArticleId IdType="pubmed">15324740</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K., Chihara J. Eosinophil activation by eotaxin—Eotaxin primes the production of reactive oxygen species from eosinophils. Allergy. 1999;54:1262–1269. doi: 10.1034/j.1398-9995.1999.00170.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1398-9995.1999.00170.x</ArticleId><ArticleId IdType="pubmed">10688429</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbert C., Zeng Q.X., Shanmugasundaram R., Garthwaite L., Oliver B.G., Kumar R.K. Response of airway epithelial cells to double-stranded RNA in an allergic environment. Transl. Respir. Med. 2014;2:11. doi: 10.1186/s40247-014-0011-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40247-014-0011-6</ArticleId><ArticleId IdType="pmc">PMC4173067</ArticleId><ArticleId IdType="pubmed">25264520</ArticleId></ArticleIdList></Reference><Reference><Citation>Djukanović R., Harrison T., Johnston S.L., Gabbay F., Wark P., Thomson N.C., Niven R., Singh D., Reddel H.K., Davies D.E. The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am. J. Respir. Crit. Care Med. 2014;190:145–154. doi: 10.1164/rccm.201312-2235OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201312-2235OC</ArticleId><ArticleId IdType="pmc">PMC4226052</ArticleId><ArticleId IdType="pubmed">24937476</ArticleId></ArticleIdList></Reference><Reference><Citation>Wos M., Sanak M., Soja J., Olechnowicz H., Busse W.W., Szczeklik A. The presence of rhinovirus in lower airways of patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 2008;177:1082–1089. doi: 10.1164/rccm.200607-973OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200607-973OC</ArticleId><ArticleId IdType="pmc">PMC2383991</ArticleId><ArticleId IdType="pubmed">18276945</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmage S.C., Perret J.L., Custovic A. Epidemiology of asthma in children and adults. Front. Pediatr. 2019;7:246. doi: 10.3389/fped.2019.00246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00246</ArticleId><ArticleId IdType="pmc">PMC6591438</ArticleId><ArticleId IdType="pubmed">31275909</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>